Alterity Therapeutics (ATHE) Shares Outstanding (Diluted) (2009 - 2025)

Alterity Therapeutics (ATHE) Shares Outstanding (Diluted) (2009 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 52.24 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 680.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 66.36 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Alterity Therapeutics 29.68 Bn 29.68 Bn - 6.40 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.40 Bn
Jun 30, 2025 6.40 Bn
Dec 31, 2024 3.65 Bn
Jun 30, 2024 3.65 Bn
Dec 31, 2023 2.43 Bn
Jun 30, 2023 2.43 Bn
Dec 31, 2022 24.06 Bn
Jun 30, 2022 24.06 Bn
Dec 31, 2021 24,051,103.27 Bn
Jun 30, 2021 16.97 Bn
Dec 31, 2020 13,234,323.72 Bn
Jun 30, 2020 8.95 Bn
Dec 31, 2019 8,683,279.81 Bn
Jun 30, 2019 272,293.95 Bn
Dec 31, 2018 272,293.95 Bn
Jun 30, 2018 272,293.95 Bn
Dec 31, 2017 272,293.95 Bn
Jun 30, 2017 272,293.95 Bn
Dec 31, 2016 272,293.95 Bn
Jun 30, 2016 272,293.95 Bn